BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33460173)

  • 1. The conundrum of polysubstance overdose.
    Pergolizzi JV; Dahan A; LeQuang JA; Raffa RB
    J Clin Pharm Ther; 2021 Oct; 46(5):1189-1193. PubMed ID: 33460173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opioid Overdose: Limitations in Naloxone Reversal of Respiratory Depression and Prevention of Cardiac Arrest.
    van Lemmen M; Florian J; Li Z; van Velzen M; van Dorp E; Niesters M; Sarton E; Olofsen E; van der Schrier R; Strauss DG; Dahan A
    Anesthesiology; 2023 Sep; 139(3):342-353. PubMed ID: 37402248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Are opioid receptor antagonists adequate for "Opioid" overdose in a changing reality?
    Peppin JF; Pergolizzi JV; Dahan A; Raffa RB
    J Clin Pharm Ther; 2021 Aug; 46(4):861-866. PubMed ID: 33913179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of opioid overdose: a brief review of naloxone pharmacology and delivery.
    Hendley TM; Hersh EV; Moore PA; Stahl B; Saraghi M
    Gen Dent; 2017; 65(3):18-21. PubMed ID: 28475079
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacology of viable mechanism agnostic respiratory stimulants for the reversal of drug-induced respiratory depression in humans.
    van Lemmen M; van der Schrier R; Dahan A; van Velzen M; Sarton E; Niesters M
    Expert Opin Drug Metab Toxicol; 2023; 19(10):671-679. PubMed ID: 37795596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of opioid overdose: current approaches and recent advances.
    Britch SC; Walsh SL
    Psychopharmacology (Berl); 2022 Jul; 239(7):2063-2081. PubMed ID: 35385972
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Update: The Risk of Opioid Toxicity and Naloxone Use in Operational K9s.
    Palmer LE; Gautier A
    J Spec Oper Med; 2017; 17(4):86-92. PubMed ID: 29256202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine to reverse respiratory depression from methadone overdose in opioid-dependent patients: a prospective randomized trial.
    Zamani N; Buckley NA; Hassanian-Moghaddam H
    Crit Care; 2020 Feb; 24(1):44. PubMed ID: 32033582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-based opioid overdose prevention programs providing naloxone - United States, 2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Feb; 61(6):101-5. PubMed ID: 22337174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Evolution of Recommended Naloxone Dosing for Opioid Overdose by Medical Specialty.
    Connors NJ; Nelson LS
    J Med Toxicol; 2016 Sep; 12(3):276-81. PubMed ID: 27271032
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a Translational Model to Assess the Impact of Opioid Overdose and Naloxone Dosing on Respiratory Depression and Cardiac Arrest.
    Mann J; Samieegohar M; Chaturbedi A; Zirkle J; Han X; Ahmadi SF; Eshleman A; Janowsky A; Wolfrum K; Swanson T; Bloom S; Dahan A; Olofsen E; Florian J; Strauss DG; Li Z
    Clin Pharmacol Ther; 2022 Nov; 112(5):1020-1032. PubMed ID: 35766413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of Opioid-Induced Ventilatory Depression Using Low-Dose Naloxone (0.04 mg): a Case Series.
    Kim HK; Nelson LS
    J Med Toxicol; 2016 Mar; 12(1):107-10. PubMed ID: 26289651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fact vs. fiction: naloxone in the treatment of opioid-induced respiratory depression in the current era of synthetic opioids.
    Dahan A; Franko TS; Carroll JW; Craig DS; Crow C; Galinkin JL; Garrity JC; Peterson J; Rausch DB
    Front Public Health; 2024; 12():1346109. PubMed ID: 38481848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal and Prevention of the Respiratory-Depressant Effects of Heroin by the Novel
    Gerak LR; Maguire DR; Woods JH; Husbands SM; Disney A; France CP
    J Pharmacol Exp Ther; 2019 Feb; 368(2):229-236. PubMed ID: 30463875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Naloxone (Narcan) nasal spray for opioid overdose.
    Med Lett Drugs Ther; 2016 Jan; 58(1485):1-2. PubMed ID: 26714239
    [No Abstract]   [Full Text] [Related]  

  • 16. Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems.
    Elzey MJ; Fudin J; Edwards ES
    Expert Opin Drug Deliv; 2017 Sep; 14(9):1045-1058. PubMed ID: 27606669
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone administration for suspected opioid overdose: An expanded scope of practice by a basic life support collegiate-based emergency medical services agency.
    Jeffery RM; Dickinson L; Ng ND; DeGeorge LM; Nable JV
    J Am Coll Health; 2017 Apr; 65(3):212-216. PubMed ID: 28059635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of opioid analgesic overdose.
    Boyer EW
    N Engl J Med; 2012 Jul; 367(2):146-55. PubMed ID: 22784117
    [No Abstract]   [Full Text] [Related]  

  • 19. On the front lines of the opioid epidemic: Rescue by naloxone.
    Skolnick P
    Eur J Pharmacol; 2018 Sep; 835():147-153. PubMed ID: 30092179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone Conundrum: Reduce risk in managing the opioid overdose patient.
    Wirth SR
    JEMS; 2016 Nov; 41(11):14-5. PubMed ID: 29188938
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.